Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

French precision fermentation startup Bon Vivant has rebranded to Verley and rolled out a range of functional animal-free ...

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

The Arkansas Integrative Metabolic Research Center will explore the potential of a novel, artificially designed, hybrid growth factor to regulate the metabolism of fat and cancer cells.

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

The project was led by Dr. Xiaoli Zhang, the Company’s research manager, whose team continues to push the boundaries of genetic engineering for spider silk production.

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

As global markets grapple with inflation fluctuations and trade policy uncertainties, Asian tech stocks have emerged as a focal point for investors seeking growth opportunities amid broader market ...